Prevalence of genotypic antimicrobial resistance in clinical Shiga toxin-producing Escherichia coli in Norway, 2018 to 2020

INTRODUCTION: Shiga toxin-producing Escherichia coli (STEC) can cause severe to fatal disease in humans. Antimicrobial treatment is sometimes necessary, but contraindicated due to undesirable clinical outcome. However, recent studies have shown promising outcomes following antimicrobial treatment. B...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramstad, Silje N., Brandal, Lin T., Taxt, Arne M., Wasteson, Yngvild, Bjørnholt, Jørgen V., Naseer, Umaer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Microbiology Society 2021
Materias:
Antimicrobial Resistance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744279/
https://www.ncbi.nlm.nih.gov/pubmed/34870582
http://dx.doi.org/10.1099/jmm.0.001454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744279/
https://www.ncbi.nlm.nih.gov/pubmed/34870582
http://dx.doi.org/10.1099/jmm.0.001454

Ejemplares similares